VE-cadherin siRNA (h) from Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

(1) Mechanobiological Adaptation to Hyperosmolarity Enhances Barrier Function in Human Vascular Microphysiological SystemAdvanced science (Weinheim, Baden-Wurttemberg, Germany)May 1, 2023Kang JH, Jang M, Seo SJ, Choi A, Shin D, Seo S, Lee SH, Kim HN.

(2) The short-chain fatty acid butyrate exerts a specific effect on VE-cadherin phosphorylation and alters the integrity of aortic endothelial cellsFrontiers in cell and developmental biologyJanuary 1, 2023Guo J, Terhorst I, Stammer P, Ibrahim A, Oberhuber A, Eierhoff T.siRNA transfection reagent (Santa Cruz, sc-29528), siRNA dilution buffer (sc-29517), VE-cadherin siRNA (h) (Santa Cruz, sc-36814), GPR41 siRNA(h) (Santa Cruz, sc-97148), and siRNA c-Src (h) (Santa Cruz, sc-29228). The cells were

(3) Evidence of a common mechanism of disassembly of adherens junctions through Gα13 targeting of VE-cadherinThe Journal of experimental medicineMarch 10, 2014Gong H, Gao X, Feng S, Siddiqui MR, Garcia A, Bonini MG, Komarova Y, Vogel SM, Mehta D, Malik AB.

(4) A VE-cadherin-PAR3-α-catenin complex regulates the Golgi localization and activity of cytosolic phospholipase A(2)α in endothelial cellsMolecular biology of the cellMay 1, 2012Odell AF, Hollstein M, Ponnambalam S, Walker JH.Santa Cruz Biotechnology; or L-012572, Dharmacon), PAR3 (s32128, s32127, s32126; Ambion) or VE-cadherin siRNA (sc-36814, Santa Cruz Biotechnology; or s2780, Ambion) for 5–6 h using Lipofectamine RNAiMAX transfection reagent

(5) MAGI-1 is required for Rap1 activation upon cell-cell contact and for enhancement of vascular endothelial cadherin-mediated cell adhesionMolecular biology of the cellFebruary 1, 2006Sakurai A, Fukuhara S, Yamagishi A, Sako K, Kamioka Y, Masuda M, Nakaoka Y, Mochizuki N.

VE-cadherin siRNA (h)